Boston Scientific (BSP:B1SX34) E10: R$1.76 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:B1SX34 Boston Scientific Corp BSP:B1SX34
75 GF Score
Price R$54.60
GF Value R$137.57
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Boston Scientific E10?

Boston Scientific BSP:B1SX34 -4.71% 75 E10 is R$1.76 as of Jun. 2026. GuruFocus rates BSP:B1SX34 with a GF Score™ of 75/100 and a GF Value™ of R$137.57 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Boston Scientific's adjusted earnings per share data for the three months ended in Jun. 2026 was R$0.781. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$1.76 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Boston Scientific's average E10 Growth Rate was 30.80% per year. During the past 3 years, the average E10 Growth Rate was 21.00% per year. During the past 5 years, the average E10 Growth Rate was 47.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Boston Scientific was 81.70% per year. The lowest was -76.50% per year. And the median was 9.90% per year.

As of today (2026-09-11), Boston Scientific's current stock price is R$54.60. Boston Scientific's E10 for the quarter that ended in Jun. 2026 was R$1.76. Boston Scientific's Shiller PE Ratio of today is 31.02.

During the past 13 years, the highest Shiller PE Ratio of Boston Scientific was 415.18. The lowest was 31.69. And the median was 96.27.


Boston Scientific  (BSP:B1SX34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Boston Scientific's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=54.60/1.76
=31.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Boston Scientific was 415.18. The lowest was 31.69. And the median was 96.27.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Boston Scientific E10 Related Terms


Boston Scientific E10 Historical Data

* Premium members only.

The historical data trend for Boston Scientific's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific E10 Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.87 0.94 1.45 1.62

Boston Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.42 1.47 1.62 1.62 1.76

BSP:B1SX34 vs EW, DXCM, GEHC: E10 Comparison

For the Medical Devices subindustry, Boston Scientific's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Shiller PE Ratio falls into.


BSP:B1SX34
75GF Score
Boston Scientific Corp BSP:B1SX34
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Boston Scientific's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.781/333.9520*333.9520
=0.781

Current CPI (Jun. 2026) = 333.9520.

Boston Scientific Quarterly Data

per share eps CPI Adj_EPS
201609 0.138 241.428 0.191
201612 0.075 241.432 0.104
201703 0.164 243.801 0.225
201706 0.091 244.955 0.124
201709 0.157 246.819 0.212
201712 -0.371 246.524 -0.503
201803 0.172 249.554 0.230
201806 0.377 251.989 0.500
201809 0.318 252.439 0.421
201812 0.262 251.233 0.348
201903 0.288 254.202 0.378
201906 0.106 256.143 0.138
201909 0.093 256.759 0.121
201912 2.904 256.974 3.774
202003 0.012 258.115 0.016
202006 -0.143 257.797 -0.185
202009 -0.162 260.280 -0.208
202012 0.129 260.474 0.165
202103 0.324 264.877 0.408
202106 0.151 271.696 0.186
202109 0.370 274.310 0.450
202112 0.085 278.802 0.102
202203 0.087 287.504 0.101
202206 0.215 296.311 0.242
202209 0.157 296.808 0.177
202212 0.118 296.797 0.133
202303 0.273 301.836 0.302
202306 0.218 305.109 0.239
202309 0.420 307.789 0.456
202312 0.416 306.746 0.453
202403 0.411 312.332 0.439
202406 0.296 314.175 0.315
202409 0.443 315.301 0.469
202412 0.580 315.605 0.614
202503 0.648 319.799 0.677
202506 0.735 322.561 0.761
202509 0.684 324.800 0.703
202512 0.614 324.054 0.633
202603 1.177 330.213 1.190
202606 0.781 333.952 0.781

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of R$1.76 mean?
Boston Scientific (BSP:B1SX34) has a E10 of R$1.76 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's E10 too high?
Boston Scientific's current E10 is R$1.76. Overall, Boston Scientific has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's E10 compare to EW and DXCM?
Boston Scientific's E10 of R$1.76 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Boston Scientific and its competitors. Boston Scientific's current E10 is R$1.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (BSP:B1SX34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$137.57, compared to a current price of R$54.60 — trading 60.3% below its estimated fair value. The current E10 is R$1.76. Boston Scientific's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Boston Scientific (BSP:B1SX34), the current E10 is R$1.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (BSP:B1SX34) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of R$54.60 is trading 60.3% below its estimated GF Value™ of R$137.57. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for BSP:B1SX34:

  • E10: R$1.76
  • GF Value™: R$137.57 vs. price of R$54.60 (60.3% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the BSP:B1SX34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
75GF Score

Get the complete analysis for BSP:B1SX34

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$54.60
Price
R$137.57
GF Value